Beranda › Nefrosis Lipoid › North Carolina
Uji klinis Nefrosis Lipoid di North Carolina
4 studi untuk Nefrosis Lipoid mencari peserta di lokasi di North Carolina.
Kota di North Carolina
Teks studi resmi (Bahasa Inggris)
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- UNC Kidney Center- Site Number : 8400021, Chapel Hill
Menerima pesertaFase 2
Usia 16 hingga 75 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06500702Nephrotic Syndrome Study Network
- University of North Carolina at Chapel Hill, Chapel Hill
- Atrium Health Levine Children's Hospital, Charlotte
Menerima pesertaStudi observasional
Hingga usia 80 · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT01209000NEPTUNE Match Study
- University of North Carolina Chapel Hill, Chapel Hill
Menerima peserta
Usia 1 hingga 80 · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT04571658Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- University of North Carolina at Chapel Hill, Chapel Hill
- Duke Molecular Physiology Institute, Durham
Menerima pesertaFase 2
Usia 1 hingga 17 · Semua jenis kelamin · Diperbarui 12 Mei 2026 · NCT05003986Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.